搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
BioSpace
1 小时
Regeneron and Sanofi’s Dupixent Tipped to Dominate COPD Biologics Market
Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...
BioSpace
14 小时
Evonik to Lay Off Additional Employees, Cutting up to 260 in Germany
Evonik’s latest layoffs are tied to discontinuing production of keto acids in Hanau, Germany, by the end of next year.
BioSpace
1 天
FDA Action Alert: Amgen, Camurus, Iterum and Lexicon
The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...
BioSpace
1 天
With Myriad Recent Approvals in Cancer, The Era of Bispecifics Is Here
As companies roll out data showing the power and improved safety profile of antibodies that target two antigens, analysts say ...
BioSpace
1 天
5 Accelerated Approvals Gone Wrong
Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market.
BioSpace
3 天
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...
BioSpace
3 天
Turnstone Biologics to Lay Off 60% of Workforce, Overhaul C-Suite
Turnstone is shifting resources to focus on clinical advancement of its selected tumor-infiltrating lymphocyte therapy as ...
BioSpace
3 天
Upstream Raises $255M IPO for Inflammatory Drugs; CAMP4 Nets $75M for RNA Work
Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...
BioSpace
3 天
Stealth Wins Adcomm’s Unexpected Support for Ultra-Rare Disease Drug Candidate
Despite substantial variability in the presented data and no well-controlled trial, the FDA advisory committee voted in favor ...
BioSpace
3 天
Teva to Pay $450M in Settlement With DOJ Over Kickback and Price-Fixing Allegations
The U.S. Department of Justice alleged that Teva violated the Anti-Kickback Statute and the False Claims Act. The payment is ...
BioSpace
3 天
Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data
Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...
BioSpace
3 天
Roche Wins First-Line Breast Cancer Nod for Oral PI3K Blocker, Projects $2.3B in Peak Sales
With the regulatory approval for advanced breast cancer, Roche’s inavolisib is a potential challenger to Novartis’ PI3K ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈